The Trump administration has expanded the controversial program to harm more communities than ever. Families and advocates nationwide are fighting back. The Trump administration is quietly using a ...

Denver's Career Service Board has tightened up eligibility rules for a popular paid leave program for Denver city employees known as "Care Bank," leading one Denver City Council member, Flor Alvidrez, ...

The 23-time Grand Slam champion is the new celebrity ambassador for telehealth company Ro. By Danielle Directo-Meston E-Commerce Editor If you purchase an independently reviewed product or service ...

Oprah Winfrey Shows Off Slim Waist During Luxe Italian Vacation After She Confessed to Using Weight-Loss Medication: Photos DOJ investigated Trump border czar Tom Homan for accepting $50,000 in cash: ...

Serena Williams is the latest celebrity to admit to using weight-loss medication. The tennis star revealed she has lost more than 30 pounds with the help of a GLP-1 prescription. “I feel great,” she ...

GLP-1 medications have taken America by storm, moving beyond clinical tools and becoming status symbols. Once accessible to only the wealthy and well-connected, they are now prescribed in clinics ...

The Trump administration is preparing a five-year pilot program that would allow Medicare and Medicaid to cover some of the most in-demand weight-loss drugs, a move that could transform obesity ...

A new fitness fad is all about catching a vibe. Vibrating plates, or vibration plate machines, have been trending on social media as a potentially effective method for losing weight and burning fat.

As more people take GLP-1 medications for weight loss, dietitians are seeing their appointments booked out for months. Channel 2’s Lori Wilson got some advice from a Piedmont Healthcare dietitian who ...

What is a Scrollbar in Tkinter? Scrollbars in Tkinter are those little bars that help you scroll when content overflows. Imagine you have a huge list or a long text area. If it doesn’t fit in the ...

Drug-induced liver injury was reported in 1 asymptomatic patient in one of the once-daily danuglipron dose-optimization studies. Pfizer has made the decision to discontinue the clinical development ...